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In the present issue of the Netherlands Heart Journal, 
Martínez-Sellés and co-workers investigated whether dif-
ferences in RV function between male and female patients 
could explain, at least in part, why women with DCM have 
a better prognosis than men. They found that RV dysfunction 
was only present in patients with more severe LV dysfunc-
tion (LVEF < 35) and that particularly in the group of patients 
with the worst LV function (LVEF < 25 %), RVEF was higher 
in women than men [8]. Although larger studies are required 
to establish causality between the effect of gender, better 
RV function and decreased mortality, this is a provocative 
study that further suggests that, also in DCM, the right ven-
tricle plays an important role. Future studies should address 
whether improved RV function is correlated with improved 
exercise capacity, and try to identify the mechanism behind 
the improvement in RV function. Interestingly, in rats with 
pulmonary hypertension, improved outcome in female rats as 
compared with their male counterparts was associated with 
reduced RV fibrosis. As the degree of fibrosis in the left ven-
tricle has been shown to be of predictive value for worsening 
of LV dysfunction in DCM [9], it would be very interesting to 
measure late gadolinium enhancement in magnetic resonance 
imaging to show a potential predictive value of RV fibrosis.
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Heart failure is mostly caused by disease of the left ven-
tricle, but the right ventricle may play a more important 
role in functional capacity and prognosis of heart failure 
patients than is often realised. Thus, right ventricular (RV) 
function has been well established to be a better marker for 
exercise capacity than left ventricular (LV) function in both 
ischaemic and dilated cardiomyopathy (DCM) [1], and is 
correlated with clinical status and outcome in patients with 
ischaemic LV dysfunction [2]. Interestingly, for a compa-
rable degree of LV dysfunction, RV function is even worse 
in patients with idiopathic DCM as compared with patients 
with ischaemic cardiomyopathy [3, 4] and, also in this 
patient group, is a predictor for outcome [5].
It is increasingly recognised that development, progres-
sion, prognosis and potentially also treatment of cardio-
vascular disease are not only dependent on the severity of 
disease, but are also influenced by age and gender. A poten-
tial explanation for the effect of gender on cardiovascular 
morbidity may be that RV function differs between men and 
women, with women generally having a smaller right ven-
tricle with a higher ejection fraction (EF) [6]. Indeed, it is 
shown that, although the incidence of pulmonary hyperten-
sion is higher in females than males, in patients with estab-
lished disease the prognosis is better in female than male 
patients, and that this is caused by a better preservation of 
RV function and a better response of the RV function to 
therapy, despite similar changes in the pulmonary vascula-
ture [7].
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